Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review. The Review of Diabetic Studies , [S. l.], p. 1039–1048, 2025. DOI: 10.70082/x94dvz94. Disponível em: https://diabeticstudies.org/index.php/RDS/article/view/1715. Acesso em: 1 feb. 2026.